chrisweber_ALZ

Director, Global Science Initiatives, Medical and Scientific Relations, Alzheimer’s Association, Views represented here are entirely my own.

[Alzheimer's Association @alzassociation]

Good morning, #AAIC25 attendees! ☀️ Are you ready to kick off an exciting week of sharing new ideas and discoveries? Scientific sessions start soon. Get today’s schedule at https://t.co/jdq5rLZXlI.

[Alzheimer's Association @alzassociation]

Is your family member or loved one living with early-onset dementia? Join us on Sept. 7 for a free, virtual meeting to learn about the latest dementia science research, get care and support resources, and share insights and experiences. Register: https://t.co/WgHFIwiNSy

[ISTAART @ISTAART]

🏆Last call for #AAIC24 awards! 🏆

Nominate for:

AAIC Lifetime Achievement Award
Blas Frangione Early Career Achievement Award
Bill Thies Award for Distinguished Service to ISTAART
Inge Grundke-Iqbal Award for Alzheimer's Research

Submit @ https://t.co/OR3QrgRtHx by Feb 9!⏰

[ISTAART @ISTAART]

It's not too late to submit to #AAIC24 - join ISTAART for an extended abstract deadline of Friday, Jan 26! Don't miss your chance to share your work with researchers, clinicians & dementia professionals from around the world!

Learn more & submit via https://t.co/n3qhzD9X0p

[Heather Snyder, PhD @HeatherAlz]

#AAIC23 #alzresearch

[chrisweber_ALZ @ChrisWeberALZ]

#AAIC23
🧠

[Alzheimer's Association @alzassociation]

The Alzheimer’s Association International Conference 2023 kicks off today with more than 10,000 of the brightest minds in dementia science convening in Amsterdam and online to share their latest research. Follow our account for breaking updates. #AAIC23

[ALZ Illinois Advocacy @AlzILAdvocacy]

THANK YOU to the advocates who rallied outside the CMS office in Chicago today! Together, our voices were heard as we demanded #AccessNOW and #MoreTime 📣💜 @ALZIMPACT @alzIllinois

[chrisweber_ALZ @ChrisWeberALZ]

So sorry Dave. Very hard to see those we love slowly slip away.

Fwiw, the Alzheimer’s Association has a 24/7 helpline (800-272-3900) staffed by amazing professionals who are there to support and help get you through those really tough days.

[David (Dave) McDermott @DavidMc68784651]

My mom is convinced that she is not at home. She became so angry with me yesterday. I did all I could do to convince her that is where she has lived for 32 years. I left her house feeling exhasted, sad, and a million other things. I must remain strong for her.

[Robert Egge @RobertEgge]

A government rule limiting access to Alzheimer’s drugs means most patients who would want newly approved Leqembi won’t be able to get it—unless the Medicare agency rewrites the rule https://t.co/5YCbOVYA4i via @WSJ

[Alzheimer's Association @alzassociation]

Playwright Garrett Davis is known for heartfelt plays that raise awareness of health issues disproportionately affecting Black Americans. We’ve partnered with him on #UnforgettablePlay to raise awareness around Alzheimer’s, a disease he knows well. https://t.co/x8j17c7cc6 #ENDALZ

[Alzheimer's Association @alzassociation]

We're joining our national partner @NFLAlumni for @BrainHealth4Men’s Black Men's Brain Health Conference. Register for free to attend online or in Tempe, AZ as we discuss representation in research and reducing brain health disparities. https://t.co/cVLjp9OKso #BMBHC #ENDALZ

[Heather Snyder, PhD @HeatherAlz]

A great start to day 1 of @HAIconference - discussion and diving deeper into the use and interpretation of emerging and existing tools used in imaging. @alzassociation is proud to be a partner of this important meeting!

[Alzheimer's Association @alzassociation]

Worth the listen! Hear our Chief Science Officer @DrMariaAlz talk through the latest treatment news around the CLARITY AD global clinical trial which confirms lecanemab can meaningfully change the course of the disease for people in the earliest stages of Alzheimer’s.

[CTAD @CTADconference]

Congratulations to Reisa Sperling and Keith Johnson on their CTAD Lifetime Achievement Awards in recognition for their extensive contributions to the advancement of AD clinical trials. #CTAD22

#alzheimer #AD #dementia #brainhealth

[ISTAART @ISTAART]

If you are at #NS22, join us at our reception on Monday, November 14, from 6:30-8:30 p.m. at the Hilton San Diego Bayfront, Sapphire Ballroom. Anyone who is a member, awardee, or interested in the work of the @alzassociation is welcome!

RSVP https://t.co/aDX0FezpV3

@SfNtweets

[Courtney Kloske, PhD @CourtneyKloske]

If you’re attending SFN - join us at the @ISTAART reception on Monday, November 14, from 6:30-8:30 p.m. at the Hilton San Diego Bayfront - Sapphire Ballroom EF. @SfNtweets @claire_e_sexton

Anyone can join - just sign-up with the link below!

https://t.co/Vhy3uzLmkQ

[Alzheimer's & Dementia Journals @alzdemjournals]

Congratulations to #DADM Associate Editor @bucklr01 on her @NIH_CommonFund @NIH Director’s New Innovator Award! This award supports exceptionally creative early career investigators proposing innovative, high-impact research. #AlzResearch(1/2)

[Alzheimer's Association @alzassociation]

.@joannepikedrph, current president of the Alzheimer’s Association, has been named our next chief executive officer. “My deep passion for public health leads me to approach Alzheimer’s and all other dementia with a particular sense of urgency.” #ENDALZ
https://t.co/Doz6hTD0vF

[Alzheimer's Association @alzassociation]

On behalf of the more than 6 million Americans living with Alzheimer’s and their families, we enthusiastically welcome the positive topline data reported today on the CLARITY AD Phase 3 clinical trial of lecanemab. Read our full statement: https://t.co/PV7bz21FXv. #Progress (1/4)

[Sudhir Sivakumaran @susivak]

#CPAD is wrapping up #AAIC22 today. Congratulations to @alzassociation for a fabulous & successful conference. Looking forward to #AAIC23 in #Amsterdam. #EndAlz @CPathInstitute @CPathCEO #AlzheimersDisease https://t.co/kMuo46Tpuz